JPWO2022249952A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022249952A5
JPWO2022249952A5 JP2023523434A JP2023523434A JPWO2022249952A5 JP WO2022249952 A5 JPWO2022249952 A5 JP WO2022249952A5 JP 2023523434 A JP2023523434 A JP 2023523434A JP 2023523434 A JP2023523434 A JP 2023523434A JP WO2022249952 A5 JPWO2022249952 A5 JP WO2022249952A5
Authority
JP
Japan
Prior art keywords
coronavirus
licorice
administered
dose
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023523434A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022249952A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/020679 external-priority patent/WO2022249952A1/ja
Publication of JPWO2022249952A1 publication Critical patent/JPWO2022249952A1/ja
Publication of JPWO2022249952A5 publication Critical patent/JPWO2022249952A5/ja
Pending legal-status Critical Current

Links

JP2023523434A 2021-05-25 2022-05-18 Pending JPWO2022249952A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021087620 2021-05-25
PCT/JP2022/020679 WO2022249952A1 (ja) 2021-05-25 2022-05-18 抗ウイルス剤

Publications (2)

Publication Number Publication Date
JPWO2022249952A1 JPWO2022249952A1 (https=) 2022-12-01
JPWO2022249952A5 true JPWO2022249952A5 (https=) 2025-03-14

Family

ID=84229988

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023523434A Pending JPWO2022249952A1 (https=) 2021-05-25 2022-05-18

Country Status (2)

Country Link
JP (1) JPWO2022249952A1 (https=)
WO (1) WO2022249952A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5288832B2 (ja) * 2008-02-27 2013-09-11 ポーラ化成工業株式会社 ヒアルロニダーゼ阻害剤及びそれを含有する組成物
JP7038992B2 (ja) * 2017-09-29 2022-03-22 丸善製薬株式会社 カンゾウの植物種の同定方法

Similar Documents

Publication Publication Date Title
JP2023041862A5 (https=)
JP2023503303A5 (https=)
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
RU2010105122A (ru) Композиции для ухода за полостью рта, продукты и способы применения
HRP20121072T1 (hr) Postupci za davanje tetrahidrobiopterina, povezani pripravci i postupci mjerenja
PE20040121A1 (es) Formulaciones farmaceuticas de liberacion controlada del 5,8,14-triazatetraciclo [10.3.1.02,11.04.9]-hexadeca-2-(11),3,5,7,9-pentaeno
JP2019524856A5 (https=)
PH12020551911A1 (en) Use of riluzole oral disintigrating tablets for treating diseases
NO20082672L (no) Anvendelse av cikletanin og andre fluorpyridiner for behandling av systolisk-dominant hypertensjon, isolert hypertensjon, oket pulstrykk og generell hypertensjon
MX2024007642A (es) Uso de tabletas de desintegracion oral de riluzol para tratar enfermedades.
JP2021113239A5 (https=)
GB2430623A (en) Medicaments for treating chronic respiratory disease
JP2019514990A5 (https=)
JP2013536837A5 (https=)
RU2008119454A (ru) Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом
CN104013638B (zh) 当药黄素及其衍生物的用途
JP2016505050A5 (https=)
JPWO2022249952A5 (https=)
EP4494700A3 (en) New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseases
HRP20100208T8 (hr) Postupak liječenja akutnog rinosinusitisa
JP2019535830A5 (https=)
MX2023000899A (es) Administracion de beta-hidroxibutirato y compuestos relacionados en humanos para el tratamiento y/o prevencion de enfermedades respiratorias.
JP2019522030A5 (https=)
PT2877192T (pt) Composições para o tratamento de fadiga relacionada com o cancro
JP2024531799A5 (https=)